Overview
Alvimopan is a peripherally acting μ opioid antagonist. It is used to avoid postoperative ileus following small or large bowel resection and accelerates the gastrointestinal recovery period.
Indication
用于手术以及使用阿片类药物导致的胃肠功能紊乱，特发性便秘以及肠易激综合症等。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/11/25 | Phase 3 | Recruiting | |||
2020/05/28 | Phase 4 | Recruiting | Scott Steele | ||
2017/11/24 | Phase 2 | Terminated | |||
2017/07/13 | Phase 3 | Recruiting | |||
2017/03/03 | Phase 4 | Terminated | |||
2016/06/02 | Phase 4 | Completed | |||
2016/05/27 | Phase 4 | Withdrawn | |||
2016/04/18 | Phase 3 | Terminated | Sharon Stein | ||
2015/03/05 | Not Applicable | Terminated | |||
2014/08/18 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Golden State Medical Supply, Inc. | 51407-870 | ORAL | 12 mg in 1 1 | 2/8/2024 | |
| Hikma Pharmaceuticals USA Inc. | 0054-0668 | ORAL | 12 mg in 1 1 | 10/24/2022 | |
| Par Pharmaceutical, Inc. | 0254-3012 | ORAL | 12 mg in 1 1 | 4/26/2023 | |
| Merck Sharp & Dohme LLC | 67919-020 | ORAL | 12 mg in 1 1 | 5/11/2022 | |
| Actavis Pharma, Inc. | 0591-2312 | ORAL | 12 mg in 1 1 | 1/31/2021 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.